2017 Vol.35, N°5 - Table of contents
September-October 2017
Review
CER10750
2017,35,5
Pg. 0721-0734
Free to view
One year in review 2017: novelties in the treatment of rheumatoid arthritis
F. Ferro, E. Elefante, N. Luciano, R. Talarico, M. Todoerti
F. Ferro, E. Elefante, N. Luciano, R. Talarico, M. Todoerti
Rapid paper
CER10716
2017,35,5
Pg. 0735-0738
Free to view
Involvement of pentraxin-3 in anti-neutrophil cytoplasmic antibody production induced by aluminum salt adjuvant
K. Nagai, Y. Aratani, A. Shibuya, K. Yamagata
K. Nagai, Y. Aratani, A. Shibuya, K. Yamagata
Full Papers
CER9854
2017,35,5
Pg. 0739-0745
Free to view
Undifferentiated connective tissue disease: predictors of evolution into definite disease
M. García-González, B. Rodríguez-Lozano, S. Bustabad, I. Ferraz-Amaro
M. García-González, B. Rodríguez-Lozano, S. Bustabad, I. Ferraz-Amaro
CER10008
2017,35,5
Pg. 0746-0751
Free to view
Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment
D. Peiteado, A. Villalba, E. Martín-Mola, A. Balsa, E. De Miguel
D. Peiteado, A. Villalba, E. Martín-Mola, A. Balsa, E. De Miguel
CER10093
2017,35,5
Pg. 0752-0765
Free to view
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the lar
F. Bartalesi, C.A. Scirè, A. Requena-Méndez, M.A. Abad, D. Buonfrate, R. Caporali, F. Conti, F. Diaz-Gonzalez, C. Fernández-Espartero, C. Martinez-Fernandez, M. Mascarello, E. Generali, G. Minisola, A. Morrone, J. Muñoz, P. Richi, G. Sakellariou, J. Salas Coronas, M. Spinicci, F. Castelli, A. Bartoloni, Z. Bisoffi, F. Gimenez-Sanchez, S. Muñoz-Fernandez, M. Matucci-Cerinic
F. Bartalesi, C.A. Scirè, A. Requena-Méndez, M.A. Abad, D. Buonfrate, R. Caporali, F. Conti, F. Diaz-Gonzalez, C. Fernández-Espartero, C. Martinez-Fernandez, M. Mascarello, E. Generali, G. Minisola, A. Morrone, J. Muñoz, P. Richi, G. Sakellariou, J. Salas Coronas, M. Spinicci, F. Castelli, A. Bartoloni, Z. Bisoffi, F. Gimenez-Sanchez, S. Muñoz-Fernandez, M. Matucci-Cerinic
CER10208
2017,35,5
Pg. 0766-0771
Free to view
Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody
F.H.C. De Souza, R. Miossi, S.K. Shinjo
F.H.C. De Souza, R. Miossi, S.K. Shinjo
CER10191
2017,35,5
Pg. 0772-0776
Free to view
Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis
R. Caporali, A. Carletto, F. Conti, S. D'angelo, R. Foti, E. Gremese, M. Govoni, F. Iannone, R. Pellerito, L. Sinigaglia
R. Caporali, A. Carletto, F. Conti, S. D'angelo, R. Foti, E. Gremese, M. Govoni, F. Iannone, R. Pellerito, L. Sinigaglia
CER10207
2017,35,5
Pg. 0777-0785
Free to view
Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjögren’s syndrome patients
M. Tandon, P. Perez, P.D. Burbelo, C. Calkins, I. Alevizos
M. Tandon, P. Perez, P.D. Burbelo, C. Calkins, I. Alevizos
CER9878
2017,35,5
Pg. 0786-0790
Free to view
Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial
P. Avila-Ribeiro, Y. Brault, M. Dougados, L. Gossec
P. Avila-Ribeiro, Y. Brault, M. Dougados, L. Gossec
CER9893
2017,35,5
Pg. 0791-0798
Free to view
Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world
M. Yang, P.J. Galebach, J.E. Signorovitch, V. Garg
M. Yang, P.J. Galebach, J.E. Signorovitch, V. Garg
CER10040
2017,35,5
Pg. 0799-0803
Free to view
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis
B. Kuriya, O. Schieir, D. Lin, J. Xiong, J. Pope, G. Boire, B. Haraoui, J.C. Thorne, D. Tin, C. Hitchon, S. Jamal, E. Keystone, V.P. Bykerk
for the CATCH Investigators
B. Kuriya, O. Schieir, D. Lin, J. Xiong, J. Pope, G. Boire, B. Haraoui, J.C. Thorne, D. Tin, C. Hitchon, S. Jamal, E. Keystone, V.P. Bykerk
for the CATCH Investigators
CER10118
2017,35,5
Pg. 0804-0809
Free to view
Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry
M. Manara, R. Caporali, E.G. Favalli, V. Grosso, F. Atzeni, P. Sarzi Puttini, R. Gorla, C. Bazzani, E. Fusaro, R. Pellerito, P.A. Rocchetta, L. Sinigaglia
M. Manara, R. Caporali, E.G. Favalli, V. Grosso, F. Atzeni, P. Sarzi Puttini, R. Gorla, C. Bazzani, E. Fusaro, R. Pellerito, P.A. Rocchetta, L. Sinigaglia
CER10155
2017,35,5
Pg. 0810-0815
Free to view
Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data
N.J. Gullick, A.N. Mian, F. Ibrahim, D. Walker, A. Hassell, P.D. Kiely, D.A. Walsh, A. Young, D.L. Scott
on behalf of TITRATE Programme Investigators
N.J. Gullick, A.N. Mian, F. Ibrahim, D. Walker, A. Hassell, P.D. Kiely, D.A. Walsh, A. Young, D.L. Scott
on behalf of TITRATE Programme Investigators
CER10169
2017,35,5
Pg. 0816-0822
Free to view
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
C. Acebes, J.L. Andreu, A. Balsa, E. Batlle, J. De toro-Santos, F. García Llorente, M.V. Hernández, B. Fernández-Gutiérrez, C. Hidalgo-Calleja, L. Mayordomo, E. Naredo, F.J. Narváez, A.M. Ortiz, J.L. Pablos, T. Pérez-Sandoval, C. Rodríguez-Lozano, O. Sánchez-Pernaute, J. Usón, J.B. Negrón, E. Loza, L. Carmona, S. Gómez Castro, M. Montoro Alvarez
C. Acebes, J.L. Andreu, A. Balsa, E. Batlle, J. De toro-Santos, F. García Llorente, M.V. Hernández, B. Fernández-Gutiérrez, C. Hidalgo-Calleja, L. Mayordomo, E. Naredo, F.J. Narváez, A.M. Ortiz, J.L. Pablos, T. Pérez-Sandoval, C. Rodríguez-Lozano, O. Sánchez-Pernaute, J. Usón, J.B. Negrón, E. Loza, L. Carmona, S. Gómez Castro, M. Montoro Alvarez
CER10153
2017,35,5
Pg. 0823-0830
Free to view
Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus
K.-J. Kim, I.-W. Baek, C.-H. Yoon, W.-U. Kim, C.-S. Cho
K.-J. Kim, I.-W. Baek, C.-H. Yoon, W.-U. Kim, C.-S. Cho
CER10011
2017,35,5
Pg. 0831-0836
Free to view
Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis
Y.-C. Tien, H.-H. Yen, Y.-M. Chiu
Y.-C. Tien, H.-H. Yen, Y.-M. Chiu
CER10073
2017,35,5
Pg. 0837-0843
Free to view
The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis
S.-R. Kwon, K.-H. Jung, M.-J. Lim, M.-J. Son, B.H. Choi, S.-G. Park, W. Park
S.-R. Kwon, K.-H. Jung, M.-J. Lim, M.-J. Son, B.H. Choi, S.-G. Park, W. Park
CER10104
2017,35,5
Pg. 0844-0849
Free to view
Endothelial dysfunction is independent of inflammation and altered CCR7 T cell expression in patients with ankylosing spondylitis.
J. Sulicka, A. Surdacki, M. Korkosz, T. Mikołajczyk, M. Strach, E. Klimek, T. Guzik, T. Grodzicki
J. Sulicka, A. Surdacki, M. Korkosz, T. Mikołajczyk, M. Strach, E. Klimek, T. Guzik, T. Grodzicki
Brief Papers
CER9622
2017,35,5
Pg. 0850-0852
Free to view
Integration of capillary microscopy and dermoscopy into the rheumatology fellow curriculum
C. Hatzis, D. Lerner, S. Paget, M. Cutolo, V. Smith, R. Spiera, J. Gordon
C. Hatzis, D. Lerner, S. Paget, M. Cutolo, V. Smith, R. Spiera, J. Gordon
CER10198
2017,35,5
Pg. 0853-0856
Free to view
Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission
S.Z. Aydin, E.K. Gunal, M. Ozata, H. Keskin, A.B. Ozturk, P. Emery, M.A. D’agostino
S.Z. Aydin, E.K. Gunal, M. Ozata, H. Keskin, A.B. Ozturk, P. Emery, M.A. D’agostino
Case Reports
CER10192
2017,35,5
Pg. 0857-0859
Free to view
No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine
D. Friedman, L. Lovig, M. Halushka, R.M. Clancy, P.M. Izmirly, J.P. Buyon
D. Friedman, L. Lovig, M. Halushka, R.M. Clancy, P.M. Izmirly, J.P. Buyon
Review
CER10063
2017,35,5
Pg. 0860-0864
Free to view
An update on the animal models in hyperuricaemia research
Y. Zhu, X. Peng, G. Ling
Y. Zhu, X. Peng, G. Ling
CER10085
2017,35,5
Pg. 0865-0871
Free to view
The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis
T. Rashid, A. Ebringer, C. Wilson
T. Rashid, A. Ebringer, C. Wilson
Letters to the Editor
CER10151
2017,35,5
Pg. 0872
Free to view
Vascularity of nail bed by ultrasound to discriminate psoriasis, psoriatic arthritis and healthy controls
S.Z. Aydin, C. Castillo-Gallego, Z.R. Ash, H. Marzo-Ortega, R. Wakefield, D. Mcgonagle
S.Z. Aydin, C. Castillo-Gallego, Z.R. Ash, H. Marzo-Ortega, R. Wakefield, D. Mcgonagle
CER10187
2017,35,5
Pg. 0873-0874
Free to view
The relevance of cluster analyses to stratify systemic lupus erythematosus: increased mortality with heavier treatment
G. De Marchi, L. Quartuccio, F. Zuliani, M. Bond, S. De Vita
G. De Marchi, L. Quartuccio, F. Zuliani, M. Bond, S. De Vita
Erratum Corrige
CER10818
2017,35,5
Pg. 0874
Free to view
Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis
B. Tejera-Segura, A.M. De vera-González, R. López-Mejías, M.A. González-Gay
B. Tejera-Segura, A.M. De vera-González, R. López-Mejías, M.A. González-Gay